Publications de la R&D d'Unicancer


High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008

J. Whelan et al, Journal of Clinical Oncology 36, no. 31 (November 1 2018) 3110-3119.doi: 10.1200/JCO.2018.78.2516


Ewing's Sarcoma of the Head and Neck: Margins are not just for surgeons.

J. Bouaoud et al, Cancer Med. 2018 Dec;7(12):5879-5888. doi: 10.1002/cam4.1801. Epub 2018 Nov 17


A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate: Data From the OS2006/Sarcoma-09 Trial.

G. Lui et al, J Clin Pharmacol. 2018 Dec;58(12):1541-1549. doi: 10.1002/jcph.1252. Epub 2018 May 23.


Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

F. duffaud et al, Lancet Oncol. 2019 Jan;20(1):120-133. doi: 10.1016/S1470-2045(18)30742-3. Epub 2018 Nov 23.


Results of Methotrexate-Etoposide-Ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/Sarcome-09 study.

N. Gaspar et al, Eur J Cancer. 2018 Jan;88:57-66. doi: 10.1016/j.ejca.2017.09.036. Epub 2017 Nov 28.


Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial.

Van den Berg H, et al. Eur J Cancer. 2015 Nov;51(16):2453-64. doi: 10.1016/j.ejca.2015.06.123. Epub 2015 Aug 10


Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial

Journal of Clinical Oncology, 10 juillet 2010, vol 28, n° 20, 3284-3291